TKT and hepatocellular carcinoma: In HCC cells, HBX was also found to trigger SH2D5 expression, and based on the HBX-mediated interaction of SH2 domain-containing 5 (SH2D5) with transketolase (TKT), STAT3 can be activated to promote HCC cell proliferation (125).